Management of Postpartum Hypertension

Blood Pressure Thresholds and Monitoring

Severe hypertension (BP ≥160/110 mmHg lasting >15 minutes) requires immediate treatment within 30-60 minutes to prevent maternal stroke and death 2, 3
For non-severe hypertension (BP 140-159/90-109 mmHg), oral antihypertensive therapy should be initiated and titrated 1
Antihypertensive medication should be continued until blood pressure has normalized, which may take days to several weeks postpartum 2, 4
Home blood pressure monitoring is recommended during the postpartum period to ensure adequate control 2, 4

The American Heart Association recommends first-line medications for postpartum hypertension, including nifedipine, amlodipine, enalapril, and labetalol, with nifedipine and amlodipine offering the advantage of once-daily dosing for better adherence 1
Calcium Channel Blockers, such as nifedipine (extended-release), offer once-daily dosing advantage 1
ACE Inhibitors, such as enalapril, are safe in lactating mothers unless the neonate is premature or has renal failure 2, 4
Beta-Blockers, such as labetalol, are commonly used but require twice-daily or more frequent dosing 1

Calcium channel blockers (nifedipine, amlodipine) are preferred first-line agents due to once-daily dosing and better postpartum efficacy 1
Diuretics (furosemide, hydrochlorothiazide, spironolactone) may reduce milk production and are generally not preferred in breastfeeding women 2, 4
For women with mild reductions in ejection fraction (40-50%), consider combination therapy with a β-blocker and ACE inhibitor 1

Evaluate for signs of end-organ damage: headache, visual disturbances, chest pain, difficulty breathing, neurological symptoms, abdominal pain, and altered mental status 3
All women with hypertension in pregnancy should have blood pressure and urine checked at 6 weeks postpartum 3

Women with pregnancy-related hypertensive disorders are at increased risk of developing hypertension, stroke, ischemic heart disease, and thromboembolic disease later in life 2, 6
Cardiovascular risk assessment and lifestyle modifications are recommended for all women with a pregnancy-related hypertensive disorder 2, 3
Ensure proper contraception planning, particularly if using ACE inhibitors, angiotensin II receptor blockers, or mineralocorticoid receptor antagonists due to potential teratogenicity in future pregnancies 1

Discontinuing antihypertensive medications too early before blood pressure has normalized 2, 4
Neglecting long-term cardiovascular risk assessment and follow-up for women with history of hypertensive disorders of pregnancy 2, 6